Abstract
The transport of the molecules inside cells is a very important topic, especially in Drug Metabolism. The experimental testing of the new proteins for the transporter molecular function is expensive and inefficient due to the large amount of new peptides. Therefore, there is a need for cheap and fast theoretical models to predict the transporter proteins. In the current work, the primary structure of a protein is represented as a molecular Star graph, characterized by a series of topological indices. The dataset was made up of 2,503 protein chains, out of which 413 have transporter molecular function and 2,090 have no transporter function. These indices were used as input to several classification techniques to find the best Quantitative Structure Activity Relationship (QSAR) model that can evaluate the transporter function of a new protein chain. Among several feature selection techniques, the Support Vector Machine Recursive Feature Elimination allows us to obtain a classification model based on 20 attributes with a true positive rate of 83% and a false positive rate of 16.7%.
Keywords: QSAR, Star Graph, topological indices, transport protein, Support Vector Machine.
Current Topics in Medicinal Chemistry
Title:Kernel-Based Feature Selection Techniques for Transport Proteins Based on Star Graph Topological Indices
Volume: 13 Issue: 14
Author(s): Carlos Fernandez-Lozano, Marcos Gestal, Nieves Pedreira-Souto, Lucian Postelnicu, Julian Dorado and Cristian Robert Munteanu
Affiliation:
Keywords: QSAR, Star Graph, topological indices, transport protein, Support Vector Machine.
Abstract: The transport of the molecules inside cells is a very important topic, especially in Drug Metabolism. The experimental testing of the new proteins for the transporter molecular function is expensive and inefficient due to the large amount of new peptides. Therefore, there is a need for cheap and fast theoretical models to predict the transporter proteins. In the current work, the primary structure of a protein is represented as a molecular Star graph, characterized by a series of topological indices. The dataset was made up of 2,503 protein chains, out of which 413 have transporter molecular function and 2,090 have no transporter function. These indices were used as input to several classification techniques to find the best Quantitative Structure Activity Relationship (QSAR) model that can evaluate the transporter function of a new protein chain. Among several feature selection techniques, the Support Vector Machine Recursive Feature Elimination allows us to obtain a classification model based on 20 attributes with a true positive rate of 83% and a false positive rate of 16.7%.
Export Options
About this article
Cite this article as:
Fernandez-Lozano Carlos, Gestal Marcos, Pedreira-Souto Nieves, Postelnicu Lucian, Dorado Julian and Munteanu Robert Cristian, Kernel-Based Feature Selection Techniques for Transport Proteins Based on Star Graph Topological Indices, Current Topics in Medicinal Chemistry 2013; 13 (14) . https://dx.doi.org/10.2174/15680266113139990119
DOI https://dx.doi.org/10.2174/15680266113139990119 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Potential for Discovery of Neuroprotective Factors in Serum and Tissue from Hibernating Species
Mini-Reviews in Medicinal Chemistry Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology Substance P Regulation in Epilepsy
Current Neuropharmacology The Orexin System: A Potential Player in the Pathophysiology of Absence Epilepsy
Current Neuropharmacology R-Type Voltage-Gated Ca<sup>2+</sup> Channels in Cardiac and Neuronal Rhythmogenesis
Current Molecular Pharmacology Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia
Central Nervous System Agents in Medicinal Chemistry Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers
Current Medical Imaging Bipolar Affective Disorder in Young People: A Review
Adolescent Psychiatry Cardiovascular Toxicity from the Perspective of Oxidative Stress, Electron Transfer, and Prevention by Antioxidants
Current Vascular Pharmacology Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Evaluation of Anticonvulsants for Possible Use in Neuropathic Pain
Current Medicinal Chemistry Osteoporotic Fracture Healing: Potential Use of Medicinal Plants from the Tropics
Current Drug Targets Editorial
Current Pediatric Reviews Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Current Pharmaceutical Design ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Relevance of CYP2C9 Function in Valproate Therapy
Current Neuropharmacology